Dr. Fellowes discusses how his team at the Peter MacCallum Cancer Centre's Molecular Pathology Lab uses the MiSeq system to transition cancer diagnosis assays to next-generation sequencing technologies. Using a deep amplicon sequencing approach with the TruSeq Custom Amplicon Cancer Panel, the team generated reproducible and accurate tumor profiling data from FFPE samples.